Back to Search Start Over

Quercetin induces an immunoregulatory phenotype in maturing human dendritic cells.

Authors :
Michalski J
Deinzer A
Stich L
Zinser E
Steinkasserer A
Knippertz I
Source :
Immunobiology [Immunobiology] 2020 Jul; Vol. 225 (4), pp. 151929. Date of Electronic Publication: 2020 Feb 24.
Publication Year :
2020

Abstract

The aryl hydrocarbon receptor (AhR) is an environmental sensor and ligand-activated transcription factor that is critically involved in the regulation of inflammatory responses and the induction of tolerance by modulating immune cells. As dendritic cells (DCs) express high AhR levels, they are efficient to induce immunomodulatory effects after being exposed to AhR-activating compounds derived from the environment or diet. To gain new insights into the molecular targets following AhR-activation in human monocyte-derived (mo)DCs, we investigated whether the natural AhR ligand quercetin or the synthetic ligand 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) modulates the function of human moDCs regarding their capability to prime naïve T cells or to migrate. As only quercetin, but not TCDD, impaired T cell activation and migration of LPS-matured DCs (LPS-DCs), we analyzed the mode of action of quercetin on moDCs in more detail. Here, we found a specific down-regulation of the immunomodulatory molecule CD83 through the direct binding of the activated AhR to the CD83 promoter. Furthermore, treatment of LPS-DCs with quercetin resulted in a reduced production of the pro-inflammatory cytokine IL-12p70 and in an increased expression of the immunoregulatory molecules disabled adaptor protein (Dab) 2, immunoglobulin-like transcript (ILT)-3, ILT4, ILT5 as well as ectonucleotidases CD39 and CD73, thereby inducing a tolerogenic phenotype in quercetin-treated maturing DCs. Overall, these data demonstrate that quercetin represents a potent immunomodulatory agent to alter human DC phenotype and function, shifting the immune balance from inflammation to resolution.<br />Competing Interests: Declaration of Competing Interest None.<br /> (Copyright © 2020 The Authors. Published by Elsevier GmbH.. All rights reserved.)

Details

Language :
English
ISSN :
1878-3279
Volume :
225
Issue :
4
Database :
MEDLINE
Journal :
Immunobiology
Publication Type :
Academic Journal
Accession number :
32115260
Full Text :
https://doi.org/10.1016/j.imbio.2020.151929